Related references
Note: Only part of the references are listed.IPASS: A Study on the Tolerability and Effectiveness of Injectable Testosterone Undecanoate for the Treatment of Male Hypogonadism in a Worldwide Sample of 1,438 Men
Michael Zitzmann et al.
JOURNAL OF SEXUAL MEDICINE (2013)
Testosterone Replacement Therapy with Long-Acting Testosterone Undecanoate Improves Sexual Function and Quality-of-Life Parameters vs. Placebo in a Population of Men with Type 2 Diabetes
Geoffrey Hackett et al.
JOURNAL OF SEXUAL MEDICINE (2013)
The effect of testosterone on mood and well-being in men with erectile dysfunction in a randomized, placebo-controlled trial
M. Spitzer et al.
ANDROLOGY (2013)
Effect of Testosterone Replacement on Response to Sildenafil Citrate in Men With Erectile Dysfunction A Parallel, Randomized Trial
Matthew Spitzer et al.
ANNALS OF INTERNAL MEDICINE (2012)
Comparison of serum testosterone and estradiol measurements in 3174 European men using platform immunoassay and mass spectrometry; relevance for the diagnostics in aging men
Ilpo T. Huhtaniemi et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2012)
Low Free Testosterone Predicts Mortality from Cardiovascular Disease But Not Other Causes: The Health in Men Study
Zoe Hyde et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Many men are receiving unnecessary testosterone prescriptions
Earn H. Gan et al.
BRITISH MEDICAL JOURNAL (2012)
REFLECTIONS ON TESTOSTERONE Evidence based medicine inevitably increases testosterone prescribing
Geoffrey Hackett et al.
BRITISH MEDICAL JOURNAL (2012)
Testosterone Replacement in Hypogonadal Men With Type 2 Diabetes and/or Metabolic Syndrome (the TIMES2 Study)
T. Hugh Jones et al.
DIABETES CARE (2011)
Onset of effects of testosterone treatment and time span until maximum effects are achieved
Farid Saad et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2011)
Hypogonadal Men Nonresponders to the PDE5 Inhibitor Tadalafil Benefit from Normalization of Testosterone Levels with a 1% Hydroalcoholic Testosterone Gel in the Treatment of Erectile Dysfunction (TADTEST Study)
Jacques Buvat et al.
JOURNAL OF SEXUAL MEDICINE (2011)
Effects of testosterone supplementation on markers of the metabolic syndrome and inflammation in hypogonadal men with the metabolic syndrome: the double-blinded placebo-controlled Moscow study
Svetlana Y. Kalinchenko et al.
CLINICAL ENDOCRINOLOGY (2010)
Low serum testosterone and increased mortality in men with coronary heart disease
Chris J. Malkin et al.
HEART (2010)
Effects of Testosterone Supplementation on Depressive Symptoms and Sexual Dysfunction in Hypogonadal Men with the Metabolic Syndrome
Erik J. Giltay et al.
JOURNAL OF SEXUAL MEDICINE (2010)
Androgens, health and sexuality in women and men
Kevan Wylie et al.
MATURITAS (2010)
Identification of Late-Onset Hypogonadism in Middle-Aged and Elderly Men
Frederick C. W. Wu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Investigation, Treatment, and Monitoring of Late-Onset Hypogonadism in Males: ISA, ISSAM, EAU, EAA, and ASA Recommendations
Christina Wang et al.
EUROPEAN UROLOGY (2009)
Testosterone therapy in hypogonadal men and potential prostate cancer risk: a systematic review
R. Shabsigh et al.
INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH (2009)
Fifty-two-Week Treatment With Diet and Exercise Plus Transdermal Testosterone Reverses the Metabolic Syndrome and Improves Glycemic Control in Men With Newly Diagnosed Type 2 Diabetes and Subnormal Plasma Testosterone
Armin E. Heufelder et al.
JOURNAL OF ANDROLOGY (2009)
Low Serum Testosterone and Estradiol Predict Mortality in Elderly Men
Asa Tivesten et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Impact of Androgen Deprivation Therapy on Cardiovascular Disease and Diabetes
Shabbir M. H. Alibhai et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Efficacy of tadalafil once daily in men with diabetes mellitus and erectile dysfunction
D. Hatzichristou et al.
DIABETIC MEDICINE (2008)
Guidelines - Management of type 2 diabetes: updated NICE guidance
Philip Home et al.
BRITISH MEDICAL JOURNAL (2008)
Endogenous testosterone and mortality due to all causes, cardiovascular disease, and cancer in men: European prospective investigation into cancer in Norfolk (EPIC-Norfolk) prospective population study
Kay-Tee Khaw et al.
CIRCULATION (2007)
Relationship between low levels of anabolic hormones and 6-year mortality in older men - The aging in the Chianti area (InCHIANTI) study
Marcello Maggio et al.
ARCHIVES OF INTERNAL MEDICINE (2007)
Clinical and biochemical assessment of hypogonadism in men with type 2 diabetes: Correlations with bioavailable testosterone and visceral adiposity
Dheeraj Kapoor et al.
DIABETES CARE (2007)
Association of specific symptoms and metabolic risks with serum testosterone in older men
Michael Zitzmann et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Diabetes and cardiovascular disease during androgen deprivation therapy for prostate cancer
Nancy L. Keating et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Low serum testosterone and mortality in male veterans
Molly M. Shores et al.
ARCHIVES OF INTERNAL MEDICINE (2006)
Testosterone undecanoate restores erectile function in a subset of patients with venous leakage: A series of case reports
AA Yassin et al.
JOURNAL OF SEXUAL MEDICINE (2006)
Testosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity and hypercholesterolaemia in hypogonadal men with type 2 diabetes
D. Kapoor et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2006)
Adverse events associated with testosterone replacement in middle-aged and older men: A meta-analysis of randomized, placebo-controlled trials
OM Calof et al.
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2005)
Intramuscular testosterone undecanoate:: Pharmacokinetic aspects of a novel testosterone formulation during long-term treatment of men with hypogonadism
M Schubert et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Frequent occurrence of hypogonadotropic hypogonadism in type 2 diabetes
S Dhindsa et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
HOMA-estimated insulin resistance is an independent predictor of cardiovascular disease in type 2 diabetic subjects - Prospective data from the Verona Diabetes Complicated Study
E Bonora et al.
DIABETES CARE (2002)
Endogenous sex hormones and the development of type 2 diabetes in older men and women: the Rancho Bernardo Study
JY Oh et al.
DIABETES CARE (2002)
Testosterone, sex hormone-binding globulin, and the development of type 2 diabetes in middle-aged men - Prospective results from the Massachusetts Male Aging Study
RK Stellato et al.
DIABETES CARE (2000)
Share Paper
